213 related articles for article (PubMed ID: 8096058)
21. Alternative splicing of the prolactin receptor gene generates a 1.7 kb RNA transcript that is linked to prolactin function in the red deer testis.
Jabbour HN; Clarke LA; Bramley T; Postel-Vinay MC; Kelly PA; Edery M
J Mol Endocrinol; 1998 Aug; 21(1):51-9. PubMed ID: 9723863
[TBL] [Abstract][Full Text] [Related]
22. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
23. Molecular cloning of the cDNA encoding a receptor tyrosine kinase-related molecule with a catalytic region homologous to c-met.
Paul SR; Merberg D; Finnerty H; Morris GE; Morris JC; Jones SS; Kriz R; Turner KJ; Wood CR
Int J Cell Cloning; 1992 Sep; 10(5):309-14. PubMed ID: 1333503
[TBL] [Abstract][Full Text] [Related]
24. Native avian c-erbB gene expresses a secreted protein product corresponding to the ligand-binding domain of the receptor.
Maihle NJ; Flickinger TW; Raines MA; Sanders ML; Kung HJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1825-9. PubMed ID: 1672045
[TBL] [Abstract][Full Text] [Related]
25. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
Guy PM; Carraway KL; Cerione RA
J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
[TBL] [Abstract][Full Text] [Related]
26. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
Pajusola K; Aprelikova O; Armstrong E; Morris S; Alitalo K
Oncogene; 1993 Nov; 8(11):2931-7. PubMed ID: 7692369
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel tyrosine kinase receptor-like molecule in neuroblastomas.
Maminta ML; Williams KL; Nakagawara A; Enger KT; Guo C; Brodeur GM; Deuel TF
Biochem Biophys Res Commun; 1992 Dec; 189(2):1077-83. PubMed ID: 1281989
[TBL] [Abstract][Full Text] [Related]
28. Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes.
Lichtenstein A; Berenson J; Gera JF; Waldburger K; Martinez-Maza O; Berek JS
Cancer Res; 1990 Nov; 50(22):7364-70. PubMed ID: 1977519
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
Kraus MH; Issing W; Miki T; Popescu NC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9193-7. PubMed ID: 2687875
[TBL] [Abstract][Full Text] [Related]
30. G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene.
Papewalis J; Nikitin AYu ; Rajewsky MF
Nucleic Acids Res; 1991 Oct; 19(19):5452. PubMed ID: 1681519
[No Abstract] [Full Text] [Related]
31. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
[TBL] [Abstract][Full Text] [Related]
32. Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
Shalaby MR; Shepard HM; Presta L; Rodrigues ML; Beverley PC; Feldmann M; Carter P
J Exp Med; 1992 Jan; 175(1):217-25. PubMed ID: 1346155
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus.
Johnston CL; Cox HC; Gomm JJ; Coombes RC
J Biol Chem; 1995 Dec; 270(51):30643-50. PubMed ID: 8530501
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins.
Osherov N; Gazit A; Gilon C; Levitzki A
J Biol Chem; 1993 May; 268(15):11134-42. PubMed ID: 8098709
[TBL] [Abstract][Full Text] [Related]
36. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of a seven transmembrane hormone receptor using differential display.
Lin HH; Stubbs LJ; Mucenski ML
Genomics; 1997 May; 41(3):301-8. PubMed ID: 9169125
[TBL] [Abstract][Full Text] [Related]
38. Alternatively spliced, germline J alpha 11-2-C alpha mRNAs are the predominant T cell receptor alpha transcripts in mouse kidney.
Madrenas J; Vincent DH; Kriangkum J; Elliott JF; Halloran PF
Mol Immunol; 1994 Sep; 31(13):993-1004. PubMed ID: 8084339
[TBL] [Abstract][Full Text] [Related]
39. Cell transformation potential of a HER2 transmembrane domain deletion mutant retained in the endoplasmic reticulum.
Hudziak RM; Ullrich A
J Biol Chem; 1991 Dec; 266(35):24109-15. PubMed ID: 1684181
[TBL] [Abstract][Full Text] [Related]
40. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden Y; Kuang WJ; Yang-Feng T; Coussens L; Munemitsu S; Dull TJ; Chen E; Schlessinger J; Francke U; Ullrich A
EMBO J; 1987 Nov; 6(11):3341-51. PubMed ID: 2448137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
